acenocumarolwzf - نتائج البحث

مالطا - الإنجليزية - Medicines Authority

sunitinib remedica 12.5mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

مالطا - الإنجليزية - Medicines Authority

sunitinib remedica 25mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents

مالطا - الإنجليزية - Medicines Authority

sunitinib remedica 37.5mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents

مالطا - الإنجليزية - Medicines Authority

sunitinib remedica 50mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastic agents - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance.metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults.pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults.experience with sutent as first-line treatment is limited (see section 5.1).